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Attenuated lipopolysaccharide-
induced inflammatory bladder 
hypersensitivity in mice deficient 
of transient receptor potential 
ankilin1
Jun Kamei1,2, Naoki Aizawa  1, Takayuki Nakagawa3,4, Shuji Kaneko  4, Haruki Kume  2, 
Yukio Homma2,5 & Yasuhiko Igawa1
Transient receptor potential ankyrin 1 (TRPA1) channel expressed by urothelial cells and bladder 
sensory nerve fibers might act as a bladder mechanosensor and nociceptive transducer. To disclose the 
role of TRPA1 in bladder function and inflammation-associated hypersensitivity, we evaluated  
in vitro and in vivo bladder function and inflammatory mechanosensory and nociceptive responses to 
intravesical lipopolysaccharide (LPS)-instillation in wild type (WT) and TRPA1-knock out (KO) mice. At 
baseline before treatment, no significant differences were observed in frequency volume variables, in 
vitro detrusor contractility, and cystometric parameters between the two groups in either sex. LPS-
instillation significantly increased voiding frequency and decreased mean voided volume at 24–48 hours 
after instillation in WT but not in TRPA1-KO mice. LPS-instillation also significantly increased the 
number of pain-like behavior at 24 hours after instillation in WT mice, but not in TRPA1-KO mice. 
Cystometry 24 hours after LPS-instillation revealed shorter inter-contraction intervals in the WT mice 
compared with TRPA1-KO mice. In contrast, inflammatory cell infiltration in the bladder suburothelial 
layer was not significantly different between the two groups. These results indicate that TRPA1 
channels are involved in bladder mechanosensory and nociceptive hypersensitivity accompanied with 
inflammation but not in physiological bladder function or development of bladder inflammation.
Transient receptor potential ankyrin 1 (TRPA1) is a nonselective cation channel expressed primarily by sensory 
neurons. TRPA1 channel is involved in mechanosensation and chemical nociception activated by exogenous 
irritants and noxious stimulation1–4. Additionally, several studies demonstrated that pharmacological inhibition 
of TRPA1 with HC-030031, a selective TRPA1 antagonist, attenuated inflammatory- and neuropathy-induced 
mechanical hypersensitivity in rodents. Similar observations in TRPA1-knock out (KO) mice suggest pathophys-
iological roles for TRPA1 channel in mechanical or thermal hypersensitivity5–8.
Immunohistochemical studies in lower urinary tract demonstrated that TRPA1 was expressed abundantly 
in the urothelium and C-fiber afferents of rat bladder (9) as well as in the mucosa of human bladder9,10. TRPA1 
mRNA expression in bladder tissue with Hunner-type interstitial cystitis, which is characterized by hypersensitive 
bladder symptoms and extensive bladder inflammation, was upregulated11–13. The proportion of bladder affer-
ent neurons expressing functional TRPA1 in L5–S1 dorsal root ganglia (DRGs) was increased, and the selective 
TRPA1 antagonist HC-030031 attenuated bladder pain-like behavior in mouse models of chemical cystitis14,15. 
These results suggested that TRPA1 might be associated with inflammatory bladder hypersensitivity. In contrast, 
a study reported that instillation of allyl isothiocyanate, a selective TRPA1 agonist, into rat bladder did not change 
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any of the cystometric parameters16. Another study demonstrated no functional changes in urethane-anesthetized 
cystometry in TRPA1-KO mice17.
In this study, we explored in vitro and in vivo bladder functional phenotypes of TRPA1-KO mice to under-
stand the physiological role of TRPA1 in regulating bladder function. We also compared changes in bladder 
histology, mechanosensation, and nociception induced by intravesical instillation of lipopolysaccharide (LPS) 
between wild type (WT) and TRPA1-KO mice to reveal the role of TRPA1 in inflammation and mechanosensory 
and nociceptive bladder hypersensitivity due to inflammation.
Results
Phenotypic bladder function of TRPA1-KO mice in the absence of LPS instillation. Frequency/
volume measurements. There were no significant differences in body weight between WT and TRPA1-KO mice 
subjected to frequency/volume measurements for either sex (male, 24.4 ± 0.5 g vs. 23.3 ± 0.4 g, female, 19.4 ± 0.2 g 
vs. 19.0 ± 0.4 g, respectively; n = 10–22 per group). There were also no significant differences in any of the fre-
quency/volume parameters between the two groups in either sex (Table 1). Mean flow rate was significantly 
higher in female mice in both WT and TRPA1-KO mice (Supplementary Table S1).
Decerebrated unanesthetized cystometry (CMG) measurements. There were no significant differences in 
any of the CMG parameters between WT and TRPA1-KO mice in either sex (n = 8–15 per group; Table 2). 
Inter-contraction interval in TRPA1-KO mice and mean voided volume in both WT and TRPA1-KO mice were 
significantly greater in female compared to male mice (Supplementary Table S1).
In vitro functional assessment of detrusor strips. There were no significant differences in the contractile responses 
to high K+ (124 mM KCl) (n = 24–30 from n = 8–10 per group), or carbachol (CCh, 10−8–10−3 M) (n = 8–10 
from n = 8–10 per group) in either sex, or adenosine triphosphate (ATP,: 10−6–10−2 M) in male mice (n = 8–10 
from n = 8–10 per group) between WT and TRPA1-KO mice (Fig. 1A–C). In contrast, the contractile responses 
to ATP in female TRPA1-KO mice were significantly weaker than those in female WT mice (n = 8 from n = 8 per 
group, Fig. 1C). There were no significant differences in the amplitude of contractions induced by electric field 
stimulation (EFS) at any frequency in either sex (n = 8–10 from n = 8–10 per group). Even after atropine admin-
istration, no significant differences were detected between the two groups in either sex.
In contrast, after repeated α, β-methylene-ATP (mATP) administration in female mice and tetrodotoxin 
(TTX) administration in male mice, the amplitude of contractions in TRPA1-KO mice were significantly smaller 
than that in WT mice in the same sex, although mATP and TTX administration markedly reduced contractility 
relative to baseline regardless of sex or genotype (Fig. 1D, Supplementary Fig. S1).
Inflammatory and nociceptive responses to LPS instillation. Because no phenotypic differences in 
bladder function were observed between WT and TRPA1-KO mice in either sex, inflammatory and nociceptive 
responses to LPS instillation were evaluated only in female mice.
Male Female
WT (n = 10) TRPA1-KO (n = 10) p value WT (n = 22) TRPA1-KO (n = 17) p value
Voiding frequency (times) 18.5 ± 1.72 16.1 ± 1.35 0.14 21.0 ± 1.30 18.0 ± 1.39 0.13
Total voided volume (ml) 2.49 ± 0.10 2.13 ± 0.17 0.09 2.32 ± 0.17 2.04 ± 0.19 0.29
Mean voided volume (μl) 136.7 ± 7.9 135.2 ± 7.6 0.89 115.8 ± 9.9 120.2 ± 11.2 0.77
Mean flow rate (μl/sec) 43.6 ± 1.5 40.7 ± 1.8 0.24 55.1 ± 3.0 56.4 ± 2.8 0.75
Water intake (ml) 4.99 ± 0.39 4.44 ± 0.33 0.32 4.24 ± 0.30 3.94 ± 0.34 0.52
Table 1. Frequency volume measurement parameters in WT and TRPA1-KO mice. WT, wild-type; TRPA1-KO, 
Transient receptor potential ankyrin 1-knockout. No significant differences between WT and TRPA1-KO mice 
of same sex (unpaired Student’s t test).
Male Female
WT (n = 8) TRPA1-KO (n = 9) p value WT (n = 15) TRPA1-KO (n = 9) p value
Basal pressure (cmH2O) 1.41 ± 0.38 1.27 ± 0.30 0.78 1.42 ± 0.25 1.24 ± 0.26 0.52
Threshold pressure (cmH2O) 5.04 ± 0.33 4.64 ± 0.43 0.48 5.93 ± 0.33 6.20 ± 0.86 0.65
Maximum pressure (cmH2O) 21.09 ± 1.83 24.84 ± 2.07 0.20 27.17 ± 1.62 28.09 ± 1.13 0.91
Inter-contraction interval (sec) 457.0 ± 70.4 480.7 ± 43.4 0.77 610.8 ± 44.1 698.1 ± 46.0 0.42
Mean voided volume (μl) 79.1 ± 10.9 86.6 ± 6.8 0.54 108.7 ± 7.5 125.7 ± 10.0 0.26
Residual volume (μl) 4.9 ± 1.9 4.0 ± 1.3 0.67 2.8 ± 0.7 3.6 ± 1.9 0.26
Table 2. Parameters of decerebrated unanesthetized cystometry measurements in WT and TRPA1-KO mice. 
WT, wild-type; TRPA1-KO, Transient receptor potential ankyrin 1-knockout. No significant differences 
between WT and TRPA1-KO mice of same sex (unpaired t-test).
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Frequency/volume measurements. There were no significant differences in voiding frequency or voided volume 
between the groups at baseline. In WT mice, LPS instillation led a significant increase in voiding frequency and a 
significant decrease in mean voided volume at 24–48 hours after instillation compared with the saline instillation 
(n = 6 per group). In contrast, in TRPA1-KO mice, there were no significant changes in either voiding frequency 
or mean voided volume after LPS instillation compared with the baseline (n = 7; Fig. 2A).
Bladder pain-like licking behavior. WT mice with LPS instillation exhibited a significant increase in the number 
of licking behavior at 24 hours after instillation compared with the baseline and the WT mice with saline instilla-
tion. In contrast, TRPA1-KO mice did not exhibit significant changes in the number of licking behavior compared 
with baseline at 24 hours after LPS instillation and significantly less behavior than the WT mice at 48 hours after 
LPS instillation (n = 6 per group; Fig. 2B).
Decerebrated unanesthetized CMG measurements. CMG measurements performed at 24 hours after LPS instil-
lation revealed that interaction between LPS-instillation and genetically TRPA1-KO in inter-contraction interval 
and voided volume. Moreover, LPS-instilled WT mice exhibited significantly shorter inter-contraction inter-
vals and lower mean voided volume than their baseline data. In contrast, LPS-instilled TRPA1-KO mice did not 
demonstrate any significant changes compared with their baseline data before LPS-instillation. TRPA1-KO mice 
showed significantly longer inter-contraction intervals and higher mean voided volumes than the LPS-instilled 
WT mice (n = 7 per group; Table 3 and Fig. 3).
Histological evaluation. Histological evaluation of the bladder specimens at 24 hours after saline or LPS 
instillation revealed that inflammatory cell infiltration and edema in the suburothelial layer were comparable 
in the bladders of both WT and TRPA1-KO mice received LPS instillation (Fig. 4B,C,E,F). In contrast, neither 
inflammatory cell infiltration nor edema was observed in the bladder of saline-instilled WT mice (Fig. 4A,D). 
Compared to those of saline-instilled WT mice, the number of infiltrating inflammatory cells was significantly 
higher in the bladders of LPS-instilled WT and TRPA1-KO mice (p = 0.0009 and 0.034, respectively), which was 
not significantly different between the WT and TRPA1-KO mice receiving LPS instillation (p = 0.24; n = 7 per 
group; Fig. 4G).
mRNA expression of TRP channels in bladder and DRG. TRPA1 mRNA was not expressed in the 
bladders or the L6 DRGs of TRPA1-KO mice.
Figure 1. Contractile responses to high K+ (A), carbachol (CCh, B), adenosine triphosphate (ATP, C), electric 
field stimulation (EFS, D). Values are expressed as means ± standard error of the mean (SEM). *p < 0.05, 
***p < 0.001 from WT mice of same sax by f-test of nonlinear regression.
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Two-way ANOVA test revealed that there were no significant interaction effects between LPS instillation and 
genetic deletion of TRPA1 in the mRNA expression changes of any TRP channels. The expression of other TRP 
channels in the bladders or L6 DRGs were not significantly different between the WT and TRPA1-KO mice (n = 5 
per group; Fig. 5A–C). LPS instillation significantly increased TRPM2 expression in the bladders compared to 
those with saline instillation (Fig. 5B), which was not observed in the L6 DRGs (Fig. 5C). LPS instillation did not 
affect the expressions of any of the other TRP channels significantly in the bladder or L6 DRGs.
Discussions
This study revealed that baseline bladder functions in TRPA1-KO mice were similar to those of WT mice and 
that TRPA1-KO mice exhibited less hypersensitive responses to LPS instillation, with histological inflammatory 
changes indistinguishable from those of WT mice. These results suggested that TRPA1 channels play minimal 
roles in physiological control of bladder function or development of LPS-induced bladder inflammation, while 
contributing to inflammation-induced bladder hypersensitivity in mice.
In vitro functional analysis of detrusor strips demonstrated that there were no significant differences in the 
contractile responses to high K+, CCh and EFS before drug administration and after atropine administration 
between WT and TRPA1-KO mice in either sex. These results suggested that intrinsic and cholinergic contractile 
property of detrusor smooth muscle were not different between WT and TRPA1-KO mice. Although female 
TRPA1-KO mice showed significantly lower contractile responses to ATP, this difference in the purinergic con-
tractile property between WT and TRPA1-KO mice may not influence total contractile function.
Figure 2. Changes over time in voiding (A) and bladder pain-like behavior (B) before and after saline or LPS 
instillation in female WT and TRPA1-KO mice. Values are expressed as mean ± SEM. *p < 0.05 from baseline by 
Dunnett’s test; #p < 0.05 from WT mice with saline instillation by Tukey’s test; †p < 0.05 from TRPA1-KO mice 
with LPS instillation by Tukey’s test.
WT TRPA1-KO p value
(n = 7) (n = 7) interaction
baseline and post 
LPS instillation 
in WT
baseline and post 
LPS instillation in 
TRPA1-KO
WT and TRPA1-
KO with LPS 
instillation
Basal pressure (cm H2O) 2.61 ± 0.56 1.92 ± 0.31 0.46 0.085 0.11 0.29
Threshold pressure (cm H2O) 8.93 ± 0.98 7.27 ± 0.43 0.15 0.061 0.33 0.16
Maximum pressure (cm H2O) 24.65 ± 0.99 28.60 ± 2.32 0.40 0.20 0.84 0.14
Inter-contraction interval (sec) 494.6 ± 62.0 768.4 ± 70.2 0.031* 0.043† 0.40 0.007‡‡
Mean voided volume (μl) 88.0 ± 13.0 128.8 ± 9.2 0.043* 0.047† 0.83 0.025‡
Residual volume (μl) 3.6 ± 1.2 7.4 ± 3.3 0.39 0.60 0.32 0.30
Table 3. Parameters of decerebrated unanesthetized CMG measurements in female WT and TRPA1-KO mice 
at 24 hours after LPS instillation and comparison to those without LPS instillation (baseline). CMG, cystometry; 
WT, wild-type; TRPA1-KO, Transient receptor potential ankyrin 1-knockout; LPS, lipopolysaccharide. 
*p < 0.05: significant interactions between genotype and LPS-instillation (two-way ANOVA test). †p < 0.05: 
significant differences from same genotype mice at baseline measurements (unpaired Student’s t test). ‡p < 0.05, 
‡‡p < 0.01: significant differences from WT mice at 24 hours after LPS instillation (unpaired Student’s t test).
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A previous CMG study in conscious free-moving rats revealed no effect on any CMG parameters with 
application of a TRPA1 antagonist16, and another CMG study showed that none of the CMG parameters in 
urethane-anesthetized TRPA1-KO mice were different from those of the WT mice. We detected no significant 
differences in in vivo measurements of frequency/volume and CMG between the WT and TRPA1-KO mice in 
either sex. These findings indicate that TRPA1 channels are unlikely to contribute to the physiological control of 
the bladder.
We then examined whether TRPA1 channels were involved in the development of bladder inflammation and 
inflammation-associated hypersensitive responses induced by intravesical instillation of LPS. LPS instillation 
in WT mice significantly increased the number of bladder pain-like behavioral events at 24 hours after instilla-
tion. LPS instillation additionally led an increase in voiding frequency and a decrease in mean voided volume at 
24–48 hours after instillation in WT mice. In contrast, TRPA1-KO mice showed weaker responses as determined 
by bladder pain-like behavior and frequent voiding provoked by LPS instillation at 24–48 hours after instillation. 
CMG measurements showed longer inter-contraction intervals and higher mean voided volumes in TRPA1-KO 
mice than those in WT mice, supporting the results of the frequency/volume measurements. Nevertheless, his-
tological evaluation of inflammatory response to LPS instillation revealed that the infiltrating inflammatory cell 
numbers were similar between the WT and TRPA1-KO mice. Taken together, these results suggested that TRPA1 
channels may not contribute to inflammation itself but were involved in increased nociception and mechanosen-
sory responses induced by bladder inflammation. A previous study demonstrated that LPS directly activates 
TRPA1, which is involved in immediate nociceptive responses to LPS, independently of Tall -like receptor 418. 
We cannot deny that the direct activation of TRPA1 by LPS contributed to the differences of the differences of 
nociceptive and micturition behaviors, even though our study evaluated the behavioral changes at 24 hours or 
later after LPS stimulation but not immediately after its instillation. Further studies evaluating the differences of 
immediate responses to LPS between WT and TRPA1-KO mice may be needed.
Previous rodent studies reported that TRPA1 antagonists attenuated bladder hyperalgesia and bladder hyperre-
flexia induced by cyclophosphamide or ifosfamide in inflammatory cystitis models14,15,19, which support the findings 
of the present study utilizing genetic deletion of TRPA1. As TRPA1-KO mice exhibited no detectable changes in 
baseline bladder functions, we speculated that there might be a compensatory increase in the expression of other 
TRP channels in TRPA1-KO mice. Previous studies, however, demonstrated that mRNA expression levels of TRPV1 
and TRPM8 were not different between the TRPA1-KO and WT mice20,21. In the present study, mRNA expression 
levels of several TRP channels that could possibly be associated with bladder function, including TRPV1, TRPV4, 
TRPM2, TRPM7, and TRPM8, did not change in the bladder or the L6 DRGs in TRPA1-KO mice.
Figure 3. Representative traces of intravesical pressure and voided volume during CMG with continuous 
saline instillation (10 µl/min) without LPS instillation (baseline) (A) and at 24 hours after LPS instillation in 
decerebrate, unanesthetized female WT and TRPA1-KO mice (B). Arrowheads: Mechanical artifacts on the 
electronic scale.
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Given that bladder hypersensitivity-associated behaviors were induced after the instillation, we expected 
an increase in expression of TRPA1channels in WT mice after LPS instillation. However, mRNA expression 
of TRPA1 did not change in the bladder or the L6 DRGs at least at 24 hours after LPS instillation. DeBerry et 
al. reported that the mRNA expression level of TRPA1 in L6–S1 DRGs of mice did not change in response to 
repeated cyclophosphamide administration14; however, in the same cystitis model, they also observed an upreg-
ulation of TRPA1 mRNA expression by single-cell reverse transcription-polymerase chain reaction (RT-PCR) 
of neuronal cells in L5–S1 DRGs innervating the bladder22. A more detailed examination such as evaluation by 
single-cell RT-PCR of the neuronal cells in L6 DRGs innervating the bladder is needed to understand the precise 
roles of TRPA1 in DRG.
Interestingly, we found that the TRPM2 mRNA expression was upregulated at 24 hours after LPS instilla-
tion in both the WT and TRPA1-KO bladders. TRPM2 channels were reported to be expressed abundantly in 
immune cells including monocytes, macrophages, and neutrophils, contributing to inflammatory and neuro-
pathic pain23,24. Thus, our observation regarding TRPM2 mRNA expression is consistent with those reports, with 
concomitant histological inflammatory changes in both mouse lines. The contribution of TRPM2 channel to 
physiological and pathophysiological bladder functions require further investigation.
Our study has several limitations. First, potential compensatory changes in bladder function due to genetic 
deletion of TRPA1, which could mask the actual functional roles of TRPA1 cannot be excluded. Second, our 
study lacked the data of the inflammatory and nociceptive responses of TRP1-KO mice with saline instilla-
tion. TRP1-KO mice with saline instillation would be expected to show the similar results to WT mice with 
saline instillation, because there were little phenotypic differences in physiological condition between WT and 
TRPA1-KO mice. However, comparing 4 groups including TRP1-KO mice with saline instillation may be more 
suitable. Moreover, we evaluated changes by cystometry, histology, and RT-PCR only at 24 hours after LPS instil-
lation. Evaluation at multiple time points is needed for precise determination of differences between WT and 
TRPA1-KO mice. Third, the degree of inflammatory changes in bladder tissue was quantified only by counting 
the number of infiltrating inflammatory cells by hematoxylin-eosin (H-E) staining and the types of inflamma-
tory cells were not identified. Immunohistochemistry staining and digital image analysis could evaluate quan-
titative evaluation of each inflammatory cells in the bladder tissue more precisely, which may help to reveal the 
differences of inflammatory changes between WT and TRAP1-KO mice13,25. Finally, we did not conduct direct 
Figure 4. Representative histological images of bladder specimens obtained from saline-instilled (A,D) 
or LPS-instilled (B,E) WT mice and LPS-instilled TRPA1-KO mice (C,F) at 24 hours after instillation and 
comparison of the number of infiltrating inflammatory cells in the submucosal layer of the bladder between the 
groups (n = 7 per group) (G). A–C: Scale bar, 200 µm. D–F: Scale bar, 100 µm. The square in each upper panel 
corresponds to the panel below. *p < 0.05, ***p < 0.001 between WT mice with saline instillation by Tukey’s test. 
There are no significant differences between the WT and the TRPA1-KO mice with LPS instillation (p = 0.24).
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evaluations of bladder afferent nerve activity to assess bladder sensory function or of elevation of the oxdative 
stress markers such as hydrogen peroxide in the bladder tissue with LPS-induced inflammation. Further investi-
gations including these evaluations are needed.
In conclusion, this is the first study demonstrating that TRPA1 channels contribute to inflammation-associated 
bladder mechanosensory and nociceptive hypersensitivity using TRPA1-KO mice. These findings suggest 
TRPA1 channels as promising pharmacological target for the treatment of inflammatory hypersensitive bladder 
disorders.
Methods
Animals. A total of 19 male and 42 female TRPA1-KO mice and 18 male and 46 female WT littermates (10–
12-weeks old) were used. Mice were maintained under standard laboratory conditions with a 12-h light (9:00 a.m. 
to 9:00 p.m.) and 12-h dark (9:00 p.m. to 9:00 a.m.) cycles with free access to food and water. Experimental pro-
tocols were approved by the animal ethics committee of the University of Tokyo Graduate School of Medicine in 
Tokyo, Japan, and were in line with the NIH guidelines for the care and use of experimental animals. TRPA1-KO 
mice were generated as reported previously26. The TRPA1-KO mouse line obtained from Jackson Laboratory (Bar 
Harbor, ME) was backcrossed with C57BL/6 J mice for at least ten generations to eliminate any background effects 
on the phenotypes.
Induction of cystitis. Under isoflurane anesthesia, a polyethylene catheter (PE-10; Clay Adams, Parsippany, 
NJ, USA) was inserted transurethrally into the bladder. After draining urine, 100 µL saline containing 2.0 mg/ml 
LPS extracted from Escherichia coli O55:B5 was instilled intravesically for one hour. As a control, vehicle (saline) 
was instilled instead of LPS. During the 1-hour instillation period, LPS or saline was exchanged to a new solution 
at 30 minutes after instillation to avoid dilution with urine. After instillation, the solution was drained, and the 
mouse was allowed to recover from anesthesia. LPS dose was determined based on a previous study27 and our 
pilot investigation.
Frequency/volume measurements. Each conscious mouse was separately placed in an MCM/
TOA-UF001-006 metabolic cage (Mitsubishi Chemical Medience, Tokyo, Japan) without any restraint, as 
reported previously28–30. After a 24-hour adaptation period, voided volume, voiding frequency, mean flow rate, 
and water intake volume were continuously recorded for 24 hours with a PowerLab (AD Instruments, Sydney, 
Australia) data acquisition system. All mice had free access to water and food during recordings.
Figure 5. mRNA expression levels of TRP channels in the bladder (A,B) and those in the L6 dorsal root ganglia 
(DRGs) (C) at 24 hours after saline- or LPS instillation in female WT and TRPA1-KO mice. No interaction 
effects were significant. **p < 0.01 between the saline instillation and LPS instillation of the bladder (two-way 
ANOVA test) (A,B). There were no significant differences in the L6 DRGs between the saline instillation and 
LPS instillation or between WT and TRPA1-KO mice (C).
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For evaluation of responses to LPS, after baseline measurements of voiding behavior for 24 hours, the mice 
received intravesical LPS or saline instillation and were placed back into the cage. After a 24-hour adaptation 
period, voiding behavior was monitored for another 48 hours.
Bladder pain-like nociceptive behavior. Assessment of bladder pain-like behavior was performed as 
described previously, with minor modifications31,32. Each mouse was placed under a lucent plastic box and habit-
uated to the environment for one hour. Next, bladder pain-like behavior such as licking or biting of the skin of the 
lower abdomen close to the bladder was monitored on a video-camera (HDR-XR500V, Sony Corporation, Tokyo, 
Japan) for the next 30 minutes as baseline33. Thereafter, the mice received intravesical LPS or saline instillation, 
and bladder pain-like behavior was monitored again for 30 minutes at 24, 48, and 72 hours after instillation. 
Number of behaviors for each mouse was counted by two investigators in a blinded manner, and the values were 
averaged.
Decerebrated unanesthetized CMG measurements. CMG measurements were performed in decer-
ebrate, unanesthetized mice according to the previously reported methods (20). In brief, under isoflurane anes-
thesia, a PE-50 catheter (Clay Adams) was implanted into the bladder through the dome. Skin from the scalp 
was removed, and skull was opened, and decerebration was performed at pre-collicular position. To eliminate 
the potential influence of anesthesia, more than two hours after surgery, the intravesical catheter was connected 
via a three-way stopcock to a pressure transducer (DX-100, Nihon Kohden, Tokyo, Japan) and a syringe pump 
(KDS 200, Muromachi Kikai, Tokyo, Japan) for saline instillation at 10 µl/min. Intravesical pressure and voided 
volume were recorded continuously using a data acquisition program (PowerLab). After stable and reproducible 
recordings were obtained, micturition cycles during a 1-hour period were averaged, and the following cysto-
metric parameters were analyzed: basal pressure (minimum bladder pressure), threshold pressure (bladder 
pressure at onset of micturition), maximum pressure (maximum bladder pressure during micturition), voided 
volume, residual volume (infusion volume–voided volume) and inter-contraction interval (duration between two 
micturitions)34.
In vitro functional studies of detrusor strips. In vitro assessment of detrusor muscle function was per-
formed as described in our previous reports28,30,35. After mice were sacrificed by pentobarbital sodium over-
dose, bladder bodies were harvested, and longitudinal, full-thickness detrusor strips were transferred to 5 ml 
organ baths. After a 2-hour equilibration period with a 10 mN stable tension, functional assessment was initi-
ated. Briefly, the strip was first exposed to a high K+-containing (124 mM KCl) Krebs solution. Then, contractile 
responses to the following stimuli were examined: CCh (10−8–10−3 M), ATP: 10−6–10−2 M, electric field stimu-
lation (EFS; pulse width, 0.8 milliseconds, 50 V; pulse duration, 10 seconds; stimulation interval, 2 minutes at 2, 
4, 8, 16, 32, and 48 Hz). After baseline EFS measurement, contractions were evoked by EFS again after 10−6 M 
atropine administration, purinoceptor desensitization by repeated administrations of 10−5 M mATP, and finally 
10−6 M TTX.
Histological examination. After mice were sacrificed by pentobarbital sodium overdose, bladders were 
harvested and opened at the dorsal side of the bladder neck along the midline toward the dome. Isolated blad-
der specimens were fixed in 4% paraformaldehyde-phosphate buffered saline, embedded in paraffin, and cut 
into 3-μm sections. Histological evaluation was performed with hematoxylin-eosin (H-E) staining, and three 
sections of submucosal layer with maximum infiltration of inflammatory cells per bladder were chosen by a 
double-blinded evaluator. Thereafter, number of infiltrating inflammatory cells was counted using a counting grid 
at 400× magnification by two investigators, and the values were averaged.
Real-time RT-PCR. After mice were sacrificed with pentobarbital sodium overdose, bladders and bilat-
eral L6 DRGs were dissected and immediately placed in RNAlater RNA stabilization reagent (QIAGEN, Venlo, 
Netherland). Total RNA extracted from tissues using miRNeasy Mini kit (QIAGEN) was reverse-transcribed to 
cDNA using SuperScript VILO Master Mix (Life Technologies, Carlsbad, CA, USA) according to the manufac-
turer’s protocol. For relative quantification of mRNA expression, real-time RT-PCR was performed using Power 
SYBR Green PCR Master Mix and gene specific primers with the StepOnePlus Real-Time PCR System (Life 
Technologies). Primer sequences are provided in Supplementary Table S2.
Drugs. CCh, ATP, atropine, and TTX were purchased from Wako Chemical (Tokyo, Japan). LPS, and mATP 
were purchased from Sigma-Aldrich (St. Louis, MO, USA). Krebs solution was composed of 118 mM NaCl, 
4.7 mM KCl, 2.5 mM CaCl2, 25.0 mM NaHCO3, 1.2 mM KH2PO4, and 11 mM glucose (pH 7.4).
Statistical analysis. All data were expressed as means ± standard error of means. Dose responses for CCh 
and ATP, and frequency responses for EFS were analyzed by f-test of nonlinear regression, and other results were 
analyzed using unpaired Student’s t test, Tukey’s test, the Mann-Whitney U test, repeated measures analysis of 
variance (ANOVA) followed by Dunnett’s post hoc analysis, or two-way ANOVA test. P < 0.05 was considered 
statistically significant.
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